Patrick Burke
27Patents
11h-index
21Co-inventors
71Inventor score
Filing activity: May 1, 2009 → Nov 22, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8697688B2 | Pyrrolobenzodiazepines used to treat proliferative diseases | Chemistry; Metallurgy | 130 | Active |
| US9242013B2 | Targeted pyrrolobenzodiazapine conjugates | Emerging Cross-Sectional Technologies | 69 | Active |
| US8163551B2 | Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation | Chemistry; Metallurgy | 27 | Active |
| US9399073B2 | Pyrrolobenzodiazepines | Chemistry; Metallurgy | 24 | Active |
| US9387259B2 | Pyrrolobenzodiazepines and targeted conjugates | Emerging Cross-Sectional Technologies | 24 | Active |
| US9592240B2 | Targeted pyrrolobenzodiazapine conjugates | Emerging Cross-Sectional Technologies | 22 | Active |
| US9713647B2 | Pyrrolobenzodiazepines and targeted conjugates | Emerging Cross-Sectional Technologies | 21 | Active |
| US9707301B2 | Pyrrolobenzodiazepines and targeted conjugates | Emerging Cross-Sectional Technologies | 21 | Active |
| US9526798B2 | Pyrrolobenzodiazepines and targeted conjugates | Emerging Cross-Sectional Technologies | 21 | Active |
| US9732084B2 | Pyrrolobenzodiazepines used to treat proliferative diseases | Chemistry; Metallurgy | 19 | Active |
| US8574907B2 | Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation | Chemistry; Metallurgy | 14 | Active |
| US8993326B2 | Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation | Chemistry; Metallurgy | 9 | Active |
| US9587019B2 | CD33 antibodies and use of same to treat cancer | Chemistry; Metallurgy | 5 | Active |
| US9816069B2 | Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation | Chemistry; Metallurgy | 5 | Active |
| US10561739B2 | Targeted pyrrolobenzodiazapine conjugates | Emerging Cross-Sectional Technologies | 4 | Active |
| US11103593B2 | Pegylated drug-linkers for improved ligand-drug conjugate pharmacokinetics | Chemistry; Metallurgy | 4 | Active |
| US10443035B2 | Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation | Chemistry; Metallurgy | 2 | Active |
| US10328084B2 | Pyrrolobenzodiazepines and targeted conjugates | Emerging Cross-Sectional Technologies | 1 | Active |
| US11319526B2 | Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation | Chemistry; Metallurgy | 1 | Active |
| US11229708B2 | Conjugates of quaternized tubulysin compounds | Human Necessities | 1 | Active |
| US11116847B2 | Methylene carbamate linkers for use with targeted-drug conjugates | Human Necessities | 1 | Active |
| US11819553B2 | Glypican 3 antibodies and conjugates thereof | Chemistry; Metallurgy | 0 | Active |
| US11793880B2 | Conjugates of quaternized tubulysin compounds | Human Necessities | 0 | Active |
| US11938194B2 | Cysteine mutated antibodies for conjugation | Chemistry; Metallurgy | 0 | Active |
| US10329352B2 | Pyrrolobenzodiazepines and targeted conjugates | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.